Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,099,947,825
+$293,988,628 QoQ
Shares Held
1,750,788
-10.8% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
4.64%
of 13F equity value
Holder Rank
#49
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $3,769,908,119 across 17 Drug Manufacturers - General names. LLY ranks #1 (55.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,750,788 | $2,099,947,825 | |
| 2 | ABBV |
AbbVie Inc.
|
2,151,394 | $541,376,786 | |
| 3 | JNJ |
Johnson & Johnson
|
1,943,962 | $493,708,029 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,500,619 | $192,829,541 | |
| 5 | AMGN |
Amgen Inc
|
438,431 | $158,764,633 | |
| 6 | PFE |
Pfizer Inc
|
4,509,295 | $108,583,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
719,424 | $90,892,028 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,140,161 | $65,696,076 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,099,947,825 | 1,750,788 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $1,805,959,197 | 1,963,490 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $500,872,930 | 466,067 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $353,713,066 | 463,582 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $360,593,428 | 462,578 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $372,624,988 | 451,169 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $344,051,064 | 445,662 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $401,187,297 | 452,838 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $403,095,094 | 445,222 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $321,739,361 | 413,568 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $228,630,550 | 392,216 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $196,978,462 | 366,724 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $171,852,093 | 366,438 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $82,545,804 | 240,364 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $79,540,932 | 217,420 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $65,379,429 | 202,194 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $64,368,084 | 198,526 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $51,066,071 | 178,322 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $45,664,414 | 165,319 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $34,742,757 | 150,369 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $34,532,661 | 150,456 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $28,141,257 | 150,633 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $25,454,149 | 150,759 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $24,644,293 | 166,493 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $24,861,777 | 151,430 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $16,954,635 | 122,222 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||